SCHEMBL6622277

SCHEMBL6622277

CC(=O)Oc1c(C(C)=O)cc(F)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
HTT P42858 3/20 0.50
MAPT P10636 3/20 0.50
HSD17B10 Q99714 3/20 0.50
TP53 P04637 1/20 0.50
GAA P10253 1/20 0.50
TSHR P16473 3/20 0.43
ABCB11 O95342 1/20 0.42
KMT2A Q03164 3/20 0.41
POLB P06746 2/20 0.41
BACE1 P56817 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
MEN1 O00255 2/20 0.40
NSD2 O96028 1/20 0.40
MCL1 Q07820 1/20 0.40
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 1/20 0.38
ESR1 P03372 1/20 0.38
ITGB3 P05106 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6907648 0.76 KDM4E (0.63) KDM4EHTTMAPTHSD17B10TP53
SCHEMBL29368738 0.76 KDM4E (0.63) KDM4EHTTMAPTHSD17B10TP53
SCHEMBL6622354 0.76 MAPT (0.68) KDM4EHTTMAPTHSD17B10TSHR
SCHEMBL6621720 0.75 MAPT (0.43) KDM4EMAPTGAAKMT2APOLB
SCHEMBL11780453 0.74 KDM4E (0.61) KDM4EHTTMAPTHSD17B10TP53
SCHEMBL23087551 0.74 HTT (0.50) KDM4EHTTMAPTHSD17B10TP53
SCHEMBL6621295 0.73 HPGD (0.46) KDM4EHTTMAPTHSD17B10TP53
SCHEMBL29371684 0.73 KDM4E (0.53) KDM4EHTTMAPTHSD17B10TP53
SCHEMBL9643280 0.73 ABCB11 (0.64) KDM4EHTTMAPTHSD17B10TP53
SCHEMBL23535302 0.73 HTT (0.60) KDM4EHTTMAPTHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474140-A1 2-OXAZOLAMINES AND THEIR USE AS 5-HT2B RECEPTOR ANTAGONISTS Pharmagene Laboratories Ltd (GB) 2004-11-10 EP disclosed
WO-2003068226-A1 2-OXAZOLAMINES AND THEIR USE AS 5-HT2B RECEPTOR ANTAGONISTS PHARMAGENE LABORATORIES LIMITED (GB) 2003-08-21 WO disclosed